tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

LRMR Stock Latest News

Larimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
Company AnnouncementsLarimar advances nomlabofusp toward accelerated Friedreich’s ataxia approval
7d ago
8K
LRMR
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
PremiumCompany Announcements
Larimar Therapeutics Executes Strategic Stock Exchange Agreement
1M ago
8K
LRMR
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
PremiumCompany Announcements
Larimar Therapeutics Highlights Promising Friedreich’s Ataxia Data
2M ago
8K
LRMR
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
PremiumCompany Announcements
Larimar Therapeutics Shows Promise in Friedreich’s Ataxia Treatment
2M ago
LRMR
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
PremiumRatings
Buy Rating for Larimar Therapeutics: Optimism in Frataxin Replacement Therapy Despite Safety Concerns
3M ago
LRMR
Positive Outlook for Larimar Therapeutics Amidst Regulatory Challenges: Buy Rating Justified
PremiumRatingsPositive Outlook for Larimar Therapeutics Amidst Regulatory Challenges: Buy Rating Justified
3M ago
LRMR
Larimar Therapeutics reports Q3 EPS (61c), consensus (42c)
Premium
The Fly
Larimar Therapeutics reports Q3 EPS (61c), consensus (42c)
3M ago
LRMR
Larimar Therapeutics sees cash runway into 4Q26
Premium
The Fly
Larimar Therapeutics sees cash runway into 4Q26
3M ago
LRMR
Larimar Therapeutics Advances Phase 1 Study on Nomlabofusp for Friedreich’s Ataxia
PremiumCompany Announcements
Larimar Therapeutics Advances Phase 1 Study on Nomlabofusp for Friedreich’s Ataxia
3M ago
LRMR
Larimar Therapeutics Reports Promising Clinical Data Update
PremiumCompany Announcements
Larimar Therapeutics Reports Promising Clinical Data Update
3M ago
8K
LRMR
3 Best Stocks to Buy Now, 10/6/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 10/6/2025, According to Top Analysts
4M ago
AMZN
LRMR
Buy Rating for Larimar Therapeutics: Promising Efficacy of Nomla in Friedreich’s Ataxia Amidst Anaphylaxis Concerns
PremiumRatings
Buy Rating for Larimar Therapeutics: Promising Efficacy of Nomla in Friedreich’s Ataxia Amidst Anaphylaxis Concerns
4M ago
LRMR
Larimar Therapeutics price target lowered to $21 from $26 at Oppenheimer
PremiumThe FlyLarimar Therapeutics price target lowered to $21 from $26 at Oppenheimer
4M ago
LRMR
Citizens JMP healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
4M ago
BIIB
DSGN
3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts
4M ago
SOC
ACVA
Larimar Therapeutics price target lowered to $7 from $10 at Baird
PremiumThe Fly
Larimar Therapeutics price target lowered to $7 from $10 at Baird
4M ago
LRMR
Buy Rating for Larimar Therapeutics Driven by Promising Data and Unmet Need in Friedreich’s Ataxia
PremiumRatings
Buy Rating for Larimar Therapeutics Driven by Promising Data and Unmet Need in Friedreich’s Ataxia
4M ago
LRMR
EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
PremiumThe Fly
EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
4M ago
EA
GD
Optimistic Buy Rating for Larimar Therapeutics Amid Promising Data and Safety Adjustments
PremiumRatings
Optimistic Buy Rating for Larimar Therapeutics Amid Promising Data and Safety Adjustments
4M ago
LRMR
Larimar Therapeutics Announces Positive Study Results
PremiumCompany AnnouncementsLarimar Therapeutics Announces Positive Study Results
4M ago
8K
LRMR
Larimar announces 25 mg, 50 mg data from OL study of nomlabofusp
Premium
The Fly
Larimar announces 25 mg, 50 mg data from OL study of nomlabofusp
4M ago
LRMR
Larimar Therapeutics provides updates on nomlabofusp program for FA
Premium
The Fly
Larimar Therapeutics provides updates on nomlabofusp program for FA
4M ago
LRMR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >